US Patent 10166190 | Patents | Expiry | Expiration | Dates

VELOXIS PHARMS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

TACROLIMUS

Supporting Information : Click here to upload a PDF

US Patent Number

10166190

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2028-05-30

Patent Use Code

Delist Requested

Application Number

206406

Patent Use Description

Product Number

2

VELOXIS PHARMS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

TACROLIMUS

Supporting Information : Click here to upload a PDF

US Patent Number

10166190

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2028-05-30

Patent Use Code

Delist Requested

Application Number

206406

Patent Use Description

Product Number

3

VELOXIS PHARMS INC

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

TACROLIMUS

Supporting Information : Click here to upload a PDF

US Patent Number

10166190

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2028-05-30

Patent Use Code

Delist Requested

Application Number

206406

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10166190

U.S. Patents

VELOXIS PHARMS INC

TACROLIMUS

10166190

Y

2028-05-30

206406

2

VELOXIS PHARMS INC

TACROLIMUS

10166190

Y

2028-05-30

206406

3

VELOXIS PHARMS INC

TACROLIMUS

10166190

Y

2028-05-30

206406

1